Intellia Therapeutics Stock Price Prediction

Intrinsic Valuation Low Real High 9.07 13.46 17.85 Details

Naive Forecast Low Next High 11.69 16.08 20.47 Details

30 Analysts Consensus Low Target High 75.76 83.25 92.41 Details

Earnings Estimates (0) Low Projected EPS High -1.6 -1.32 -1 Details

Intellia Therapeutics After-Hype Price Prediction Density Analysis

Intellia Therapeutics Estimiated After-Hype Price Volatility

Intellia Therapeutics Stock Price Prediction Analysis

Expected Return	Period Volatility	Hype Elasticity	Related Elasticity	News Density	Related Density	Expected Hype
0.43	4.38	0.21	0.32	10 Events / Month	7 Events / Month	In about 10 days

Latest traded price	Expected after-news price	Potential return on next major news	Average after-hype volatility
15.41	15.21	0.00	876.00   Notes

Intellia Therapeutics Hype Timeline

Intellia Therapeutics is now traded for 15.41. The entity has historical hype elasticity of -0.21, and average elasticity to hype of competition of -0.32. Intellia is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is now at -0.43%. %. The volatility of related hype on Intellia Therapeutics is about 588.71%, with the expected price after the next announcement by competition of 15.09. About 91.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.61. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Intellia Therapeutics recorded a loss per share of 5.45. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 10 days. Check out Intellia Therapeutics Basic Forecasting Models to cross-verify your projections. For information on how to trade Intellia Stock refer to our How to Trade Intellia Stock guide.

Intellia Therapeutics Related Hype Analysis

Intellia Therapeutics Additional Predictive Modules

Most predictive techniques to examine Intellia price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Intellia using various technical indicators. When you analyze Intellia charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of Intellia Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Intellia Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Intellia Therapeutics based on analysis of Intellia Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.

The number of cover stories for Intellia Therapeutics depends on current market conditions and Intellia Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Intellia Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Intellia Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Intellia Therapeutics' future price predictability will typically decrease when Intellia Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Intellia Therapeutics often depends not only on the future outlook of the potential Intellia Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Intellia Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.

When running Intellia Therapeutics' price analysis, check to measure Intellia Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intellia Therapeutics is operating at the current time. Most of Intellia Therapeutics' value examination focuses on studying past and present price action to predict the probability of Intellia Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intellia Therapeutics' price. Additionally, you may evaluate how the addition of Intellia Therapeutics to your portfolios can decrease your overall portfolio volatility.